Cost-effective Analysis of Subcutaneous vs Sublingual Immunotherapy From the Payor's Perspective.
Frances Mei HardinPeter N EskanderChristine FranzesePublished in: OTO open (2021)
When compared to SCIT, SLIT is economically favorable and should be considered the financially conscious option for patients with >40% adherence to therapy.